Quince Therapeutics (QNCX) Confirms Unsolicited $1.60/sh Acquisition Offer from Echo Lake Capital

Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform patients’ lives, today confirmed that it received an unsolicited offer to acquire the company from Echo Lake Capital. Quince’s Board of Directors, consistent with its fiduciary responsibilities, will carefully review and evaluate the proposal to determine the course of action it believes is in the best interests of the company and its stockholders. Quince stockholders need not take any action at this time.

You May Also Be Interested In

• Blackstone (BX) to Acquire Tropical Smoothie Cafe
• EQT Corp. (EQT) PT Lowered to $46 at Wolfe Research
• IBM (IBM) to Acquire HashiCorp (HCP) for $35/sh Cash or $6.4B